Nemosia

Winterthur, Switzerland Founded: 2020 • Age: 6 yrs
Preclinical services for neurological disorders are provided.
Request Access

About Nemosia

Nemosia is a company based in Winterthur (Switzerland) founded in 2020.. Nemosia has raised $164.55 thousand across 1 funding round from investors including Venture Kick. Nemosia offers products and services including PET Tracer for NMDA Receptor and 18 F-OF-NB1. Nemosia operates in a competitive market with competitors including Rhenovia Pharma, Afraxis, Wave Neuro, Neuro-Sys and Cerca Insights, among others.

  • Headquarter Winterthur, Switzerland
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Social
    *********
Operational Areas
Healthcare → Healthcare Services & Infrastructure
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $164.55 K (USD)

    in 1 rounds

  • Latest Funding Round
    $164.55 K (USD), Seed

    Aug 30, 2021

  • Investors
  • Employee Count
    Employee Count
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Nemosia

Nemosia offers a comprehensive portfolio of products and services, including PET Tracer for NMDA Receptor and 18 F-OF-NB1. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Radioactive molecule for PET scans to detect brain neurodegeneration early.

Synthesized tracer evaluated for NMDA receptor imaging in non-human primates.

Funding Insights of Nemosia

Nemosia has successfully raised a total of $164.55K through 1 strategic funding round. The most recent funding activity was a Seed round of $164.55 thousand completed in August 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 1
  • Last Round Seed — $164,549
  • First Round

    (30 Aug 2021)

  • Investors Count 1
Date Amount Transaction Name Valuation Lead Investors Investors
Aug, 2021 Amount Seed - Nemosia Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Nemosia

Nemosia has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Venture Kick. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Investor Description Founded Year Domain Location
University backed startup accelerator
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Nemosia

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Nemosia

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Nemosia Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Nemosia

Nemosia operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Rhenovia Pharma, Afraxis, Wave Neuro, Neuro-Sys and Cerca Insights, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Biosimulation technology is provided for CNS drug discovery and development.
domain founded_year HQ Location
Provides comprehensive CNS pharmaceutical screening technologies for pre-clinical evaluations.
domain founded_year HQ Location
Preclinical services to neurological science are provided.
domain founded_year HQ Location
Preclinical CRO services for neurodegenerative diseases are offered by Neuro-Sys.
domain founded_year HQ Location
Provides preclinical services in behavioral pharmacology for research and development.
domain founded_year HQ Location
Provider of in vivo and ex vivo services to drug developers for neurological disorders
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Nemosia

Frequently Asked Questions about Nemosia

When was Nemosia founded?

Nemosia was founded in 2020 and raised its 1st funding round 1 year after it was founded.

Where is Nemosia located?

Nemosia is headquartered in Winterthur, Switzerland. It is registered at Winterthur, Zurich, Switzerland.

Is Nemosia a funded company?

Nemosia is a funded company, having raised a total of $164.55K across 1 funding round to date. The company's 1st funding round was a Seed of $164.55K, raised on Aug 30, 2021.

What does Nemosia do?

Nemosia was founded in 2020 and is based in Winterthur, Switzerland. Preclinical services are delivered by the company in the neuroscience sector, focusing on neurological disorders. Early-stage research and testing for potential therapies are supported through these operations. The domain nemosia.com is utilized for online presence. Activities are centered on preclinical development to aid pharmaceutical and biotech advancements in the region.

Who are the top competitors of Nemosia?

Nemosia's top competitors include Brains On-Line, Neuro-Sys and Rhenovia Pharma.

What products or services does Nemosia offer?

Nemosia offers PET Tracer for NMDA Receptor and 18 F-OF-NB1.

Who are Nemosia's investors?

Nemosia has 1 investor. Key investors include Venture Kick.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available